Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Inflammatory pathways confer resistance to chemoradiotherapy in anal squamous cell carcinoma ; volume:8 ; number:1 ; day:23 ; month:4 ; year:2024 ; pages:1-10 ; date:12.2024
npj precision oncology ; 8, Heft 1 (23.4.2024), 1-10, 12.2024

Creator
Martin, D.
Rödel, F.
Hehlgans, S.
Looso, M.
Ziegler, P. K.
Fleischmann, M.
Diefenhardt, M.
Fries, L.
Kalinauskaite, G.
Tinhofer, Ingeborg
Zips, D.
Gani, C.
Rödel, C.
Fokas, E.
Contributor
SpringerLink (Online service)

DOI
10.1038/s41698-024-00585-y
URN
urn:nbn:de:101:1-2407090926449.668676970109
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:56 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Martin, D.
  • Rödel, F.
  • Hehlgans, S.
  • Looso, M.
  • Ziegler, P. K.
  • Fleischmann, M.
  • Diefenhardt, M.
  • Fries, L.
  • Kalinauskaite, G.
  • Tinhofer, Ingeborg
  • Zips, D.
  • Gani, C.
  • Rödel, C.
  • Fokas, E.
  • SpringerLink (Online service)

Other Objects (12)

Anal canal squamous carcinoma

Anal canal squamous carcinoma

C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy

C-reactive protein-to-albumin ratio as prognostic marker for anal squamous cell carcinoma treated with chemoradiotherapy

Squamous papilloma of the anal canal

Squamous papilloma of the anal canal

Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review

Photobiomodulation as a treatment for dermatitis caused by chemoradiotherapy for squamous cell anal carcinoma: case report and literature review

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy

Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma

IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma

HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma

HPV positive, wild type TP53, and p16 overexpression correlate with the absence of residual tumors after chemoradiotherapy in anal squamous cell carcinoma

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma

Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma

Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma

Sarcopenia is associated with hematologic toxicity during chemoradiotherapy in patients with anal carcinoma

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy

Multiparametric MRI as an outcome predictor for anal canal cancer managed with chemoradiotherapy

Anal squamous cell carcinoma in a high HIV prevalence population

Anal squamous cell carcinoma in a high HIV prevalence population

Related objects